PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
APFED

Press Release


Receive press releases from APFED: By Email RSS Feeds:

2018 AAAAI/APFED Best Abstract on EGIDs Awards Recipients Announced


Researchers recognized for best-scoring abstracts focusing on eosinophilic gastrointestinal disease.

Atlanta, GA, March 09, 2018 --(PR.com)-- The American Partnership for Eosinophilic Disorders (APFED) announced today the two recipients of the 2018 AAAAI/APFED Best Abstract on EGIDs Awards. To recognize outstanding research abstracts on eosinophil-associated gastrointestinal diseases (EGIDs) presented at the Joint Congress of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the World Allergy Organization, APFED funded a $750 award both to the best-scoring abstract by a Fellow-in-Training and by a Member.

The awards are intended to help defray travel costs to the meeting so that the researchers may present their findings to their peers. Abstract award winners may go on to successfully compete for grants from APFED or from other funding mechanisms.

The 2018 AAAAI/APFED Best Abstracts on EGIDs recipients are Peter S. Capucilli, MD (Fellow-in-Training), Children’s Hospital of Philadelphia, for his abstract entitled “A Comparison of Comorbid Diagnoses in Children with and without Eosinophilic Esophagitis in a Large Primary Care Population,” and Ichiro Nomura, MD (Member), National Research Institute for Child Health and Development, for his abstract entitled “Elevated Serum TSLP, IL-33, 6Ckine and MCP-3 Levels in School Children or Older Patients with Eosinophilic Gastroenteritis.”

The awards were made possible thanks to the generous donations to APFED’s HOPE on the Horizon Research Program, which has enabled the organization to contribute more than $2 million for the research of eosinophil-associated diseases since the fund began in 2005.

About the American Partnership for Eosinophilic Disorders (APFED)
The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. www.apfed.org

About the American Academy of Allergy, Asthma & Immunology (AAAAI)
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,000 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.
Contact Information
APFED
Mary Jo Strobel
(713) 493-7749
Contact
www.apfed.org

Click here to view the list of recent Press Releases from APFED
Promote Your Business